These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3325930

  • 1. Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit.
    Boland DM, van Gestel WC, MacLaren DM, de Jong D.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S58-9. PubMed ID: 3325930
    [Abstract] [Full Text] [Related]

  • 2. [Pefloxacin: clinical experience].
    Bertrand A, Janbon F, Jourdan J, Jonquet O, Santoni A.
    Pathol Biol (Paris); 1985 Jun 11; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M, Pechère JC, Marchou B, Auckenthaler R.
    Am J Med; 1986 Jun 30; 80(6B):138-42. PubMed ID: 3088999
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
    Lauwers S, Vincken W, Naessens A, Pierard D.
    J Antimicrob Chemother; 1986 Apr 30; 17 Suppl B():111-5. PubMed ID: 3458696
    [Abstract] [Full Text] [Related]

  • 5. Pefloxacin in the treatment of lower respiratory tract infections in geriatrics.
    Vanderdonckt J.
    J Int Med Res; 1987 Apr 30; 15(4):234-9. PubMed ID: 3477513
    [Abstract] [Full Text] [Related]

  • 6. Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.
    Martin C, Gouin F, Fourrier F, Junginger W, Prieur BL.
    J Antimicrob Chemother; 1988 Jun 30; 21(6):795-9. PubMed ID: 3165975
    [Abstract] [Full Text] [Related]

  • 7. [A new challenge to the treatment of acute lower respiratory tract bacterial infections].
    Deng W.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep 30; 21(9):515. PubMed ID: 11360500
    [No Abstract] [Full Text] [Related]

  • 8. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
    Berardi-Grassias LD, Roy O.
    Pathol Biol (Paris); 1987 May 30; 35(5):467-72. PubMed ID: 3112705
    [Abstract] [Full Text] [Related]

  • 9. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    Pechère JC, Marchou B, Michéa-Hamzehpour M, Auckenthaler R.
    J Antimicrob Chemother; 1986 Mar 30; 17 Suppl A():11-8. PubMed ID: 3086276
    [Abstract] [Full Text] [Related]

  • 10. [Pefloxacin: evaluation and clinical prospects].
    Modaï J.
    Rev Med Interne; 1986 Mar 30; 7(2):205-10. PubMed ID: 3459223
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
    Rolin O, Huet Y, Bouanchaud DH.
    J Antimicrob Chemother; 1986 Apr 30; 17 Suppl B():49-52. PubMed ID: 2940215
    [Abstract] [Full Text] [Related]

  • 12. [Preliminary study on norfloxacin in pulmonary Pseudomonas aeruginosa infections].
    Vercelloni M, Cogo R, Furcolo F, Di Franco G, Rosaschino F.
    G Ital Chemioter; 1985 Apr 30; 32(2):489-91. PubMed ID: 3833592
    [No Abstract] [Full Text] [Related]

  • 13. Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Bayer AS, Greenberg DP, Yih J.
    Chemotherapy; 1988 Apr 30; 34(1):46-55. PubMed ID: 3162413
    [Abstract] [Full Text] [Related]

  • 14. [Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
    Fourrier F, Chopin C, Lestavel P, Savage C.
    Presse Med; 1986 Jun 28; 15(26):1240. PubMed ID: 2944094
    [No Abstract] [Full Text] [Related]

  • 15. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
    Geddes DM.
    Chest; 1988 Aug 28; 94(2 Suppl):140S-145S. PubMed ID: 3293940
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New quinolones in the treatment of joint and bone infections.
    Desplaces N, Acar JF.
    Rev Infect Dis; 1988 Aug 28; 10 Suppl 1():S179-83. PubMed ID: 3279491
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.
    Verbist L.
    J Antimicrob Chemother; 1986 Apr 28; 17 Suppl B():11-7. PubMed ID: 3086278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.